| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.494 | 0.011 | 0.494 | Potassium channel blocker | |||
| 0.477 | 0.002 | 0.477 | Histamine N-methyltransferase inhibitor | 0.154 0.013 CID_154699868 | ||
| 0.349 | 0.026 | 0.388 | Cyclic AMP phosphodiesterase inhibitor | 0.388 0.018 CID_154699868 | CID_154699868 | |
| 0.387 | 0.066 | 0.387 | MAP kinase kinase 6 inhibitor | |||
| 0.355 | 0.051 | 0.361 | Spasmolytic | 0.361 0.049 CID_154699868 | CID_154699868 | |
| 0.305 | 0.003 | 0.305 | Somatostatin 4 agonist | 0.073 0.009 CID_154699868 | ||
| 0.308 | 0.006 | 0.308 | Histamine H1 receptor antagonist | |||
| 0.34 | 0.046 | 0.34 | Sodium/bile acid cotransporter inhibitor | 0.321 0.061 CID_154699868 | ||
| 0.298 | 0.01 | 0.298 | Antihistaminic | |||
| 0.292 | 0.01 | 0.292 | Histamine antagonist | |||
| 0.388 | 0.112 | 0.388 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.341 | 0.078 | 0.341 | Vasodilator, peripheral | |||
| 0.289 | 0.061 | 0.289 | Cardiotonic | |||
| 0.275 | 0.049 | 0.275 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.225 | 0.007 | 0.225 | Nitric-oxide synthase inhibitor | |||
| 0.274 | 0.068 | 0.274 | Ca(v)3.3 blocker | |||
| 0.223 | 0.02 | 0.223 | Chelator | |||
| 0.221 | 0.021 | 0.221 | DNA intercalator | |||
| 0.255 | 0.056 | 0.255 | MAP-kinase-activated kinase 5 inhibitor | |||
| 0.292 | 0.094 | 0.292 | Vasodilator, coronary | 0.289 0.097 CID_154699868 | ||
| 0.204 | 0.01 | 0.204 | CXC chemokine 4 receptor antagonist | |||
| 0.257 | 0.063 | 0.257 | HERG channel blocker | |||
| 0.225 | 0.032 | 0.225 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.213 | 0.021 | 0.213 | MAP kinase kinase 5 inhibitor | |||
| 0.301 | 0.115 | 0.301 | GABA C receptor rho-3 antagonist | |||
| 0.193 | 0.009 | 0.193 | Inducible nitric-oxide synthase inhibitor | |||
| 0.247 | 0.068 | 0.247 | Potassium channel (Voltage-sensitive) blocker | |||
| 0.311 | 0.133 | 0.311 | Analgesic | |||
| 0.25 | 0.074 | 0.25 | Superoxide dismutase inhibitor | |||
| 0.201 | 0.032 | 0.201 | Anesthetic local | |||
| 0.189 | 0.026 | 0.189 | Alpha 2b adrenoreceptor antagonist | |||
| 0.168 | 0.009 | 0.168 | Acetylcholine release stimulant | |||
| 0.187 | 0.029 | 0.187 | Nav1.3 sodium channel blocker | |||
| 0.169 | 0.019 | 0.169 | Gastric antisecretory | |||
| 0.161 | 0.015 | 0.161 | 5 Hydroxytryptamine 1F antagonist | |||
| 0.156 | 0.013 | 0.156 | Toll-Like receptor 3 antagonist | |||
| 0.205 | 0.065 | 0.205 | CDC-like kinase 4 inhibitor | |||
| 0.155 | 0.016 | 0.155 | Interleukin 2 antagonist | |||
| 0.162 | 0.025 | 0.162 | Heat shock protein 70 antagonist | 0.147 0.054 CID_154699868 | ||
| 0.144 | 0.011 | 0.144 | CXC chemokine receptor antagonist | |||
| 0.208 | 0.076 | 0.208 | Nitric-oxide synthase stimulant | |||
| 0.182 | 0.051 | 0.182 | Acetylcholine M1 receptor antagonist | |||
| 0.153 | 0.023 | 0.153 | Sphingomyelinase inhibitor | |||
| 0.129 | 0.005 | 0.129 | Potassium channel small-conductance Ca-activated blocker | |||
| 0.184 | 0.061 | 0.184 | Antipruritic | |||
| 0.18 | 0.057 | 0.189 | Cytidine deaminase inhibitor | 0.189 0.053 CID_154699868 | CID_154699868 | |
| 0.202 | 0.081 | 0.202 | MAP kinase kinase 2 inhibitor | |||
| 0.17 | 0.051 | 0.17 | Toll-Like receptor 9 antagonist | |||
| 0.119 | 0.002 | 0.119 | Histamine H1 receptor agonist | |||
| 0.153 | 0.036 | 0.153 | Calcium channel N-type blocker | |||
| 0.137 | 0.02 | 0.137 | CYP2A6 inhibitor | |||
| 0.235 | 0.121 | 0.235 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | |||
| 0.124 | 0.011 | 0.124 | 5 Hydroxytryptamine 5 antagonist | |||
| 0.184 | 0.071 | 0.184 | LIM domain kinase 1 inhibitor | |||
| 0.158 | 0.046 | 0.158 | Nav1.6 sodium channel blocker | |||
| 0.211 | 0.099 | 0.211 | Aldehyde oxidase inhibitor | |||
| 0.111 | 0.005 | 0.111 | Somatostatin 4 antagonist | 0.027 0.013 CID_154699868 | ||
| 0.154 | 0.05 | 0.154 | Cholinergic antagonist | |||
| 0.147 | 0.045 | 0.147 | Acetylcholine muscarinic antagonist | 0.112 0.075 CID_154699868 | ||
| 0.134 | 0.034 | 0.134 | Protein kinase C mu inhibitor | |||
| 0.15 | 0.05 | 0.15 | Acetylcholine antagonist | |||
| 0.106 | 0.007 | 0.158 | Glucosylceramidase inhibitor | 0.158 0.004 CID_154699868 | CID_154699868 | |
| 0.104 | 0.008 | 0.104 | Histamine agonist | |||
| 0.152 | 0.057 | 0.152 | Calcium channel blocker | |||
| 0.117 | 0.022 | 0.117 | Rho-associated kinase I inhibitor | |||
| 0.154 | 0.059 | 0.154 | Cytokine production inhibitor | |||
| 0.217 | 0.124 | 0.217 | Gastrin inhibitor | |||
| 0.215 | 0.126 | 0.215 | Ca2+/calmodulin-dependent kinase IV inhibitor | |||
| 0.097 | 0.008 | 0.097 | Somatostatin agonist | |||
| 0.156 | 0.069 | 0.156 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | |||
| 0.177 | 0.091 | 0.177 | Growth factor agonist | |||
| 0.177 | 0.091 | 0.177 | Focal adhesion kinase 2 inhibitor | |||
| 0.122 | 0.036 | 0.122 | Alpha 2 adrenoreceptor antagonist | |||
| 0.146 | 0.062 | 0.146 | Cyclin-dependent kinase 7 inhibitor | |||
| 0.09 | 0.007 | 0.09 | Somatostatin 2 antagonist | |||
| 0.089 | 0.007 | 0.089 | Squalene epoxidase inhibitor | |||
| 0.12 | 0.043 | 0.12 | CDC-like kinase 3 inhibitor | |||
| 0.285 | 0.21 | 0.285 | Caspase 9 stimulant | |||
| 0.151 | 0.079 | 0.151 | Cyclin-dependent kinase 8 inhibitor | |||
| 0.108 | 0.038 | 0.108 | Polo-like kinase-1 inhibitor | |||
| 0.102 | 0.032 | 0.102 | Histamine H2 receptor antagonist | |||
| 0.086 | 0.017 | 0.086 | Cyclin-dependent kinase 6 inhibitor | |||
| 0.131 | 0.062 | 0.131 | Epidermal growth factor receptor kinase inhibitor | |||
| 0.114 | 0.047 | 0.114 | Insulin receptor antagonist | |||
| 0.165 | 0.099 | 0.165 | Anesthetic general | |||
| 0.165 | 0.099 | 0.165 | Ca2+/calmodulin-dependent protein kinase inhibitor | |||
| 0.069 | 0.004 | 0.069 | Corticotropin releasing factor 1 receptor antagonist | |||
| 0.085 | 0.021 | 0.085 | 5 Hydroxytryptamine 5A antagonist | |||
| 0.218 | 0.156 | 0.32 | Antithrombotic | 0.32 0.077 CID_154699868 | CID_154699868 | |
| 0.079 | 0.019 | 0.079 | Potassium channel (Ca-activated) blocker | |||
| 0.079 | 0.019 | 0.079 | Fibroblast growth factor 4 antagonist | |||
| 0.086 | 0.027 | 0.086 | S-adenosyl-L-methionine decarboxylase inhibitor | |||
| 0.065 | 0.006 | 0.065 | Endothelial nitric-oxide synthase inhibitor | |||
| 0.066 | 0.009 | 0.066 | Benzodiazepine antagonist | |||
| 0.08 | 0.023 | 0.08 | 5 Hydroxytryptamine 6 antagonist | |||
| 0.135 | 0.079 | 0.135 | Growth factor antagonist | |||
| 0.117 | 0.063 | 0.117 | 5 Hydroxytryptamine 2B antagonist | |||
| 0.196 | 0.143 | 0.196 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.074 | 0.022 | 0.074 | Botulinum neurotoxin type A inhibitor | |||
| 0.056 | 0.006 | 0.056 | CDK4/cyclin D3 inhibitor | |||
| 0.158 | 0.107 | 0.158 | Clk dual-specificity kinase inhibitor | |||
| 0.059 | 0.008 | 0.059 | 5 Hydroxytryptamine 1D agonist | |||
| 0.18 | 0.129 | 0.285 | Peptidyltransferase inhibitor | 0.285 0.03 CID_154699868 | CID_154699868 | |
| 0.069 | 0.019 | 0.069 | Epithelial sodium channel blocker | |||
| 0.06 | 0.01 | 0.06 | Diamine oxidase inhibitor | |||
| 0.054 | 0.004 | 0.054 | Myristoyl transferase inhibitor | |||
| 0.096 | 0.048 | 0.096 | Epidermal growth factor antagonist | |||
| 0.078 | 0.031 | 0.078 | Acetylcholine M2 receptor antagonist | |||
| 0.119 | 0.071 | 0.119 | MAP kinase 12 inhibitor | |||
| 0.1 | 0.053 | 0.1 | Protein kinase C delta inhibitor | |||
| 0.077 | 0.03 | 0.077 | Orexin receptor antagonist | |||
| 0.088 | 0.043 | 0.088 | Alpha 2a adrenoreceptor antagonist | |||
| 0.051 | 0.006 | 0.051 | Benzodiazepine receptor peripheral-type antagonist | |||
| 0.048 | 0.003 | 0.048 | Cyclin T1 inhibitor | |||
| 0.086 | 0.042 | 0.086 | Rho-associated kinase inhibitor | |||
| 0.072 | 0.029 | 0.072 | Dopamine uptake inhibitor | |||
| 0.111 | 0.068 | 0.111 | Calcium channel (voltage-sensitive) blocker | |||
| 0.072 | 0.029 | 0.072 | Tyrosine-protein kinase EMT inhibitor | |||
| 0.11 | 0.067 | 0.11 | MAP kinase 13 inhibitor | |||
| 0.107 | 0.066 | 0.107 | Protein kinase C gamma inhibitor | |||
| 0.084 | 0.044 | 0.084 | Porphobilinogen synthase inhibitor | |||
| 0.09 | 0.05 | 0.09 | ErbB-3 antagonist | |||
| 0.074 | 0.035 | 0.074 | 5 Hydroxytryptamine 1D antagonist | |||
| 0.149 | 0.109 | 0.149 | Death-associated protein kinase 2 inhibitor | |||
| 0.06 | 0.021 | 0.06 | CXC chemokine 1 receptor antagonist | |||
| 0.075 | 0.036 | 0.075 | 5 Hydroxytryptamine uptake inhibitor | |||
| 0.056 | 0.017 | 0.056 | Geranyltranstransferase inhibitor | |||
| 0.102 | 0.064 | 0.102 | Alpha 2c adrenoreceptor antagonist | |||
| 0.154 | 0.116 | 0.154 | I kappa B kinase epsilon inhibitor | |||
| 0.061 | 0.023 | 0.061 | Immunoglobulin Fc receptor antagonist | |||
| 0.092 | 0.055 | 0.092 | Pim-3 kinase inhibitor | |||
| 0.19 | 0.153 | 0.19 | MAP kinase kinase 3 inhibitor | |||
| 0.073 | 0.037 | 0.073 | Exportin-1 inhibitor | |||
| 0.044 | 0.008 | 0.044 | Adenosine uptake inhibitor | |||
| 0.089 | 0.053 | 0.089 | 5 Hydroxytryptamine 2C antagonist | |||
| 0.074 | 0.038 | 0.074 | Cyclin-dependent kinase 4 inhibitor | |||
| 0.1 | 0.065 | 0.1 | Folate antagonist | |||
| 0.08 | 0.046 | 0.08 | MAP kinase kinase 7 inhibitor | |||
| 0.08 | 0.047 | 0.08 | Vanilloid antagonist | |||
| 0.046 | 0.013 | 0.046 | CF transmembrane conductance regulator antagonist | |||
| 0.151 | 0.119 | 0.151 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | |||
| 0.088 | 0.057 | 0.088 | Insulin growth factor antagonist | |||
| 0.073 | 0.041 | 0.073 | Protein kinase C alpha inhibitor | |||
| 0.056 | 0.025 | 0.056 | Topoisomerase II beta inhibitor | |||
| 0.097 | 0.066 | 0.097 | Cyclin-dependent kinase 9 inhibitor | |||
| 0.085 | 0.055 | 0.085 | Insulin like growth factor 1 antagonist | |||
| 0.074 | 0.044 | 0.074 | Amidase inhibitor | |||
| 0.049 | 0.02 | 0.049 | Neurokinin 2 agonist | |||
| 0.053 | 0.024 | 0.053 | Thymidylate synthase inhibitor | |||
| 0.086 | 0.058 | 0.086 | Stem cell growth factor agonist | |||
| 0.117 | 0.089 | 0.117 | Toll-Like receptor antagonist | |||
| 0.087 | 0.059 | 0.087 | Ca(v)2.2 blocker | |||
| 0.085 | 0.058 | 0.085 | Bcr-Abl kinase inhibitor | |||
| 0.046 | 0.019 | 0.046 | TRPM8 blocker | |||
| 0.068 | 0.042 | 0.068 | 5 Hydroxytryptamine 1B antagonist | |||
| 0.063 | 0.038 | 0.063 | Acetylcholine M5 receptor antagonist | |||
| 0.123 | 0.1 | 0.139 | CC chemokine 6 receptor antagonist | 0.139 0.042 CID_154699868 | CID_154699868 | |
| 0.061 | 0.038 | 0.061 | Phosphodiesterase 1A inhibitor | |||
| 0.03 | 0.007 | 0.03 | Histamine H4 receptor agonist | |||
| 0.106 | 0.084 | 0.106 | Cyclin-dependent kinase inhibitor | |||
| 0.108 | 0.086 | 0.108 | Aldehyde dehydrogenase inhibitor | |||
| 0.05 | 0.028 | 0.05 | CC chemokine 4 receptor antagonist | |||
| 0.056 | 0.034 | 0.056 | Melanin-concentrating hormone receptor 1 antagonist | |||
| 0.1 | 0.078 | 0.1 | Platelet activating factor antagonist | |||
| 0.06 | 0.039 | 0.06 | CDK4/cyclin D inhibitor | |||
| 0.074 | 0.053 | 0.074 | Acetylcholine M4 receptor antagonist | |||
| 0.099 | 0.079 | 0.099 | GABA C receptor antagonist | |||
| 0.127 | 0.108 | 0.127 | Adenylate cyclase stimulant | |||
| 0.081 | 0.063 | 0.081 | Estrogen-related receptor beta agonist | |||
| 0.03 | 0.012 | 0.03 | Hedgehog signaling activator | |||
| 0.067 | 0.049 | 0.067 | Phenylalanine 4-hydroxylase inhibitor | |||
| 0.155 | 0.137 | 0.155 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | |||
| 0.095 | 0.077 | 0.095 | Adenylate kinase inhibitor | 0.091 0.084 CID_154699868 | ||
| 0.166 | 0.15 | 0.166 | DNA damaging | |||
| 0.071 | 0.055 | 0.071 | Rho-associated kinase II inhibitor | |||
| 0.139 | 0.123 | 0.139 | ATPase inhibitor | |||
| 0.109 | 0.094 | 0.109 | Ca2+/calmodulin-dependent kinase II delta inhibitor | |||
| 0.061 | 0.046 | 0.061 | Prolactin release inhibitor | |||
| 0.126 | 0.113 | 0.126 | CDC-like kinase 2 inhibitor | |||
| 0.03 | 0.017 | 0.03 | MAP3K8 inhibitor | |||
| 0.041 | 0.029 | 0.041 | Glutamate (mGluR1a) antagonist | |||
| 0.075 | 0.062 | 0.075 | Viral attachment inhibitor | |||
| 0.085 | 0.074 | 0.085 | Platelet activating factor alpha antagonist | |||
| 0.037 | 0.026 | 0.037 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | |||
| 0.055 | 0.045 | 0.055 | Protein kinase C iota inhibitor | |||
| 0.068 | 0.058 | 0.068 | Histone deacetylase SIRT1 stimulant | |||
| 0.068 | 0.058 | 0.068 | Histone deacetylase stimulant | |||
| 0.057 | 0.047 | 0.057 | Alpha 2 adrenoreceptor agonist | |||
| 0.106 | 0.096 | 0.106 | Protein-tyrosine kinase Lyn inhibitor | |||
| 0.035 | 0.027 | 0.035 | ATM kinase inhibitor | |||
| 0.051 | 0.042 | 0.051 | Nicotinic receptor alpha7 subunit antagonist | |||
| 0.038 | 0.03 | 0.038 | Histone deacetylase 9 inhibitor | |||
| 0.093 | 0.085 | 0.093 | 5 Hydroxytryptamine antagonist | |||
| 0.046 | 0.038 | 0.046 | Transforming growth factor beta 1 antagonist | |||
| 0.187 | 0.179 | 0.187 | Insulysin inhibitor | |||
| 0.028 | 0.021 | 0.028 | 5 Hydroxytryptamine 6 agonist | |||
| 0.088 | 0.082 | 0.088 | GABA C receptor agonist | |||
| 0.068 | 0.062 | 0.068 | Orexin receptor 1 antagonist | |||
| 0.016 | 0.011 | 0.016 | CDK2/cyclin A3 inhibitor | |||
| 0.043 | 0.038 | 0.043 | Proto-oncogene tyrosine-protein kinase Met inhibitor | |||
| 0.135 | 0.13 | 0.135 | Psychostimulant | |||
| 0.142 | 0.138 | 0.142 | Platelet aggregation inhibitor | |||
| 0.047 | 0.043 | 0.047 | mTOR inhibitor | |||
| 0.127 | 0.124 | 0.127 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | |||
| 0.112 | 0.109 | 0.112 | Peroxidase inhibitor | |||
| 0.019 | 0.017 | 0.032 | Adenosine kinase inhibitor | 0.032 0.009 CID_154699868 | CID_154699868 | |
| 0.05 | 0.048 | 0.05 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | |||
| 0.031 | 0.029 | 0.031 | CDK6/cyclin D3 inhibitor | |||
| 0.102 | 0.1 | 0.102 | Lck kinase inhibitor | |||
| 0.028 | 0.026 | 0.028 | Thiazolidinedione | |||
| 0.034 | 0.033 | 0.034 | Cyclin D3 inhibitor | |||
| 0.122 | 0.121 | 0.122 | GABA C receptor rho-2 antagonist | |||
| 0.052 | 0.051 | 0.052 | Sphingosine 1-phosphate receptor 3 antagonist | |||
| 0.073 | 0.072 | 0.073 | MAP-kinase-activated kinase inhibitor | |||
| 0.031 | 0.03 | 0.031 | Protein kinase (CK2) beta inhibitor | |||
| 0.063 | 0.062 | 0.063 | Protein kinase C beta inhibitor | |||
| 0.044 | 0.043 | 0.044 | Phosphatidylinositol 3-kinase beta inhibitor | |||
| 0.179 | 0.185 | 0.231 | Cholesterol antagonist | 0.231 0.139 CID_154699868 | CID_154699868 | |
| 0.166 | 0.174 | 0.313 | DNA synthesis inhibitor | 0.313 0.039 CID_154699868 | CID_154699868 | |
| 0.111 | 0.124 | 0.15 | Anticoagulant | 0.15 0.08 CID_154699868 | CID_154699868 | |
| 0.114 | 0.128 | 0.126 | Hemostatic | 0.126 0.102 CID_154699868 | CID_154699868 | |
| 0.069 | 0.105 | 0.083 | NADH dehydrogenase inhibitor | 0.083 0.069 CID_154699868 | CID_154699868 | |
| 0.175 | 0.237 | 0.257 | Toll-Like receptor 7 agonist | 0.257 0.142 CID_154699868 | CID_154699868 | |
| 0.157 | 0.228 | 0.201 | Angiogenesis inhibitor | 0.201 0.168 CID_154699868 | CID_154699868 | |
| 0.17 | 0.244 | 0.259 | Toll-Like receptor agonist | 0.259 0.14 CID_154699868 | CID_154699868 | |
| 0.031 | 0.106 | 0.061 | Alpha-mannosidase inhibitor | 0.061 0.025 CID_154699868 | CID_154699868 | |
| 0.021 | 0.096 | 0.047 | Antimetabolite | 0.047 0.034 CID_154699868 | CID_154699868 | |
| 0.022 | 0.104 | 0.055 | Mannosidase inhibitor | 0.055 0.02 CID_154699868 | CID_154699868 | |
| 0.004 | 0.1 | 0.022 | Ileal bile acid transport inhibitor | 0.022 0.008 CID_154699868 | CID_154699868 | |
| 0.062 | 0.195 | 0.157 | Thrombolytic | 0.157 0.077 CID_154699868 | CID_154699868 | |
| 0.047 | 0.18 | 0.09 | Expectorant | 0.09 0.081 CID_154699868 | CID_154699868 | |
| 0.013 | 0.152 | 0.051 | Phosphorylase inhibitor | 0.051 0.03 CID_154699868 | CID_154699868 | |
| 0.083 | 0.247 | 0.207 | Hypolipemic | 0.207 0.089 CID_154699868 | CID_154699868 | |
| 0.111 | 0.325 | 0.193 | Immunomodulator | 0.193 0.172 CID_154699868 | CID_154699868 | |
| 0.021 | 0.256 | 0.049 | Glucose-6-phosphate translocase inhibitor | 0.049 0.041 CID_154699868 | CID_154699868 | |
| 0.019 | 0.316 | 0.052 | Heparanase inhibitor | 0.052 0.04 CID_154699868 | CID_154699868 | |
| 0.047 | 0.359 | 0.318 | Immunostimulant | 0.318 0.074 CID_154699868 | CID_154699868 | |
| 0.064 | 0.422 | 0.286 | Immunosuppressant | 0.286 0.124 CID_154699868 | CID_154699868 | |
| 0.027 | 0.393 | 0.096 | Beta glucuronidase inhibitor | 0.096 0.076 CID_154699868 | CID_154699868 | |
| 0.026 | 0.418 | 0.194 | Lipid peroxidase inhibitor | 0.194 0.044 CID_154699868 | CID_154699868 | |
| 0.017 | 0.479 | 0.064 | Factor IXa inhibitor | 0.064 0.024 CID_154699868 | CID_154699868 | |
| 0.012 | 0.494 | 0.04 | Antibiotic Aminoglycoside-like | 0.04 0.021 CID_154699868 | CID_154699868 | |
| 0.042 | 0.589 | 0.462 | Antibacterial | 0.462 0.052 CID_154699868 | CID_154699868 | |
| 0.027 | 0.612 | 0.153 | Platelet adhesion inhibitor | 0.153 0.102 CID_154699868 | CID_154699868 | |
| 0.005 | 0.644 | 0.157 | Selectin antagonist | 0.157 0.017 CID_154699868 | CID_154699868 | |
| 0.009 | 0.741 | 0.167 | Free radical scavenger | 0.167 0.127 CID_154699868 | CID_154699868 | |
| 0.023 | 0.768 | 0.185 | Hypoglycemic | 0.185 0.127 CID_154699868 | CID_154699868 | |
| 0.025 | 0.775 | 0.176 | Hepatoprotectant | 0.176 0.083 CID_154699868 | CID_154699868 | |
| 0.022 | 0.783 | 0.389 | Cyclophilin D inhibitor | 0.389 0.097 CID_154699868 | CID_154699868 | |
| 0.008 | 0.79 | 0.208 | Antioxidant | 0.208 0.108 CID_154699868 | CID_154699868 | |
| 0.009 | 0.828 | 0.303 | Angiogenesis stimulant | 0.303 0.048 CID_154699868 | CID_154699868 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |